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Deriving a Preference-Based Measure for People With Duchenne Muscular
Dystrophy From the DMD-QoL
Donna Rowen, PhD, Philip Powell, PhD, Clara Mukuria, PhD, Jill Carlton, PhD, Richard Norman, PhD, John Brazier, PhD
A B S T R A C T
Objectives: This study generates a preference-based measure for capturing the quality of life of people with Duchenne
muscular dystrophy (DMD) from a new measure of quality of life, DMD-QoL.
Methods: A health state classification system was derived from the DMD-QoL based on psychometric performance of items,
factor analysis, and item response theory analysis. Preferences for health states described by the classification system were
elicited using an online discrete choice experiment survey with life years as an additional attribute, from members of the UK
general population (n = 1043). Discrete choice experiment data was modeled using a conditional fixed-effects logit model and
utility estimates were directly anchored on the 1 to 0 full health-dead scale.
Results: The health state classification system has 8 dimensions: mobility, difficulty using hands, difficulty breathing, pain,
tiredness, worry, participation, and feeling good about yourself. The standard model had mostly statistically significant co-
efficients and reflected the instrument’s monotonic structure. However, 2 dimensions had inconsistent coefficients (where
utility increased as health worsened) and a consistent model was estimated that merged adjacent inconsistent severity levels.
The best state defined by the classification system has a value of 1 and the worst state has a value of 20.559.
Conclusion: The modeled results enable DMD-QoL-8D utility values to be generated using DMD-QoL or DMD-QoL-8D data to
generate QALYs for people with DMD. QALYs can then be used to inform economic models of the cost-effectiveness of
interventions in DMD. Future research comparing the psychometric performance of DMD-QoL-8D to existing generic
preference-based measures, including EQ-5D-5L, is recommended.
Keywords: condition-specific preference based measure, DMD-QoL, Duchenne muscular dystrophy, utilities, QALYs.
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Introduction
Cost-effectiveness analysis is an important tool internationally
for assessing whether new or existing healthcare interventions are
cost-effective, by assessing incremental costs and benefits. Bene-
fits of treatments can be captured using quality adjusted life years
(QALYs), which capture both quality and quantity of life. Quality of
life (QoL) is measured by assigning a health state utility value on a
1 to 0 full health-dead scale, and this is multiplied with duration
in the health state to generate the QALY. Health state utility values
are typically measured using generic preference-based measures
(PBM), following recommendations by international agencies on
how benefits should be measured for assessing new in-
terventions.1,2 However, generic PBM are not always available,
appropriate, or sufficient, and there is a role for other ways of
measuring utilities that may be more accurate for a particular
condition or population. In these circumstances, condition-
specific PBM are one option for generating health state utility
values, which are typically developed from existing validated
patient reported outcome measures (PROM). Condition-specific
PBM are often patient focused and more relevant for patients
than generic PBM and better able to focus on condition-specific
and symptomatic aspects that are relevant for a particular con-
dition or population. However, the use of condition-specific PBM
may impact on the comparability and generalizability of QALYs
across different conditions.
Duchenne muscular dystrophy (DMD) is a rare inherited con-
dition that predominantly affects boys. The disease has an esti-
mated incidence of around 1:5000 live male births.3 Physical and
functional problems are manifest in people with DMD from as
early as 2 years4 due to an absence of the dystrophin protein,
which causes muscle damage and progressive weakness. Gradual
impairments in physical functioning occur over time, eventually
resulting in cardiovascular and respiratory problems. The life ex-
pectancy of people with DMD is shortened as a result, at a median
of 30 years,5 yet advances in healthcare are progressively
improving this estimate. There is a large impact on caregivers of
people with DMD, including financial burden.6 There is no known
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curative treatment for DMD, and clinicians aim to treat symptoms
and slow progression and, in doing so, improve patients’ QoL.
PROM are typically used to assess QoL. Research using PROM to
assess QoL in DMD has reported that it is lower than general
population comparison groups,7 including in the domains of
physical and social functioning.8,9 These findings notwithstanding,
concerns have been raised about the capacity of available PROM
and PBM to optimally measure QoL in DMD.10,11
For a PROM to be useful, it is essential that it has a high reli-
ability and validity to measure the construct of interest (QoL) in
the patient group of interest (DMD). A key element of the validity
of a PROM is content validity, which includes comprehensiveness,
or that all the key elements of QoL that are important to patients
are assessed.12 A recent review catalogued a number of relevant
QoL themes identified in patients with DMD, such as participation
and accessibility,7 which may not be optimally assessed by avail-
able PROM and PBM. A complementary review evaluating the
content of PROM used to assess QoL in DMD, using Consensus-
Based Standards for the Selection of Health Measurement In-
struments (COSMIN) methods,12 concluded that no PROM had
high quality evidence for its content validity in DMD.13 Measuring
QoL in DMD is further complicated by the typical use of different
PROM across the life course, impeding comparisons across time,
patients, and disease stage, which could be remedied with a
common instrument.
The DMD-QoL was recently developed as a condition-specific
PROM to address some of the problems identified with existing
measures and provide a content valid measure of QoL in people
with DMD from childhood to adulthood.14 An aim in the devel-
opment of the DMD-QoL was to produce a PROM that could be
adapted into a PBM for use in cost utility analysis.15 Alternative,
available generic PBM, such as EQ-5D, were evaluated as having
poor content validity for DMD,13 although these have been pre-
viously used to generate utility estimates.16 Previous QoL ques-
tionnaires designed for use specifically in people with muscular
dystrophy have not been designed for use in economic analysis,
and thus cannot be used in cost utility calculations directly.
This study generates a DMD-specific PBM to produce health
state utility values for the DMD-QoL. A PBM consists of (1) a
classification system used to describe the QoL of a respondent
through assigning them to a health state, and (2) a scoring system
used to generate utility values for all health states defined by the
classification system on the 1 to 0 full health-dead scale used to
generate QALYs.
The derivation of the DMD-specific PBM involved 3 stages.
First, a classification system was derived from the DMD-QoL.
Second, an online discrete choice experiment (DCE) was con-
ducted to elicit preferences. Third, the DCE data was modeled to
generate utility values for all health states defined by the classi-
fication system. The DMD-specific PBM enables utility values to be
generated from existing DMD-QoL data. These utility values can
then be used to estimate QALYs for use in cost-effectiveness an-
alyses of interventions for DMD, for submission to agencies such
as NICE (National Institute of Health and Care Excellence).17
Methods
DMD-QoL
The DMD-QoL is a new condition-specific PROM developed to
measure QoL in people with DMD aged 7 and above.14 The mea-
sure has 14 items covering 3 QoL dimensions (physical func-
tioning, psychological impact, and social participation). Each item
has 4 frequency levels that describe the severity of each attribute
(ie, never, sometimes, a lot of the time, and all of the time).
The development of the DMD-QoL involved multiple stages
that followed the process outlined in a published protocol15 and
included patient, caregiving, and clinician involvement
throughout. The DMD-QoL was developed across multiple stages,
involving qualitative interviews with people with DMD; face
validation exercises with patients, caregivers, and clinicians; and
analyses of psychometric data from an online patient survey. Pa-
tient and public involvement and engagement was embedded
throughout development of the PROM.
Derivation of health state classification system for
valuation
The first step in valuing the DMD-QoL was to establish a
multidimensional health state classification system (HSC) that
would be amendable to valuation using DCE. As valuation via DCE
can be a cognitively demanding task, and because people can only
typically process between 5 and 9 pieces of information,18 it is
common to limit the number of dimensions in an HSC. We chose
to limit the HSC to 8 dimensions (plus duration), which is a
number of dimensions that has been successfully used previously
in the HSCs for other PBM (for example19-21).
Initial psychometric analyses of the DMD-QoL suggested a
correlated 3-factor structure (physical functioning, psychological
impact, and social participation). As the DMD-QoL has 14 items
with a 3-factor structure, some prioritization across items was
thus necessary to reduce the length of the questionnaire for
valuation, while aiming to retain representation across the un-
derlying 3 factors. Selection of DMD-QoL items for the HSC was
determined by selecting $2 items for each underlying factor.
Items were selected based on their perceived importance in the
underlying qualitative and developmental work for the DMD-
QoL14 and performance of the items psychometrically and in item
response theory (IRT) analyses (using a rating scale model), based
on an approach22 used to develop several PBM (for
example19,20,23). Items were judged for selection based on avail-
able data using the following criteria: (1) show adequate item infit
and outfit (based on mean squared residual values) of between 0.5
and 1.524; (2) generate the largest spread (and thus discrimina-
tion) across each latent factor22); (3) maximize independence
between items for use in valuation (for example see25), using the
average intra-factor correlation (ie, average correlation with items
within the same factor) based on a polychoric correlation matrix;
(4) minimize floor and ceiling effects and missing data; and (5)
minimize disordered thresholds and differential item functioning,
if possible. Differential item functioning was assessed based on
report method (self-report vs proxy report) and age ($16 years or
7-15 years) at a 1% alpha level26). Finally, all items had to make
sense for valuation, in combination with their proposed severity
levels (eg, being embarrassed “all of the time” may be unrealistic).
Selection for the HSC relied on data produced from an online
survey using a draft (27 item) version of the DMD-QoL, reported in
detail elsewhere.14 DMD-QoL data existed for a valid sample of 102
people with DMD (n = 37 self- or assisted self-reported and n = 66
proxy reported). All participants were male, and patients’ ages
ranged from 7 to 44 years, but were skewed toward younger ages
(M = 15.77, SD = 7.87). A full description of the sample is available
elsewhere.14 All psychometric and IRT analyses were conducted in
R x64 3.6.1,27 utilising packages psych,28 and lavaan29 for the
psychometrics and eRm30 and lordif26 for the IRT analyses.
Valuation technique
Discrete choice experiments are being increasingly used to
generate health state utility values.31,32 A DCE task for health state
valuation typically involves a choice between 2 health profiles,
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where each profile is described using a selected level for each
dimension and the duration of this health state followed by death.
Participants are asked to select their preferred profile. The inclu-
sion of duration as an attribute in the DCE alongside the QoL di-
mensions enables the modeled latent values from the DCE to be
directly anchored onto the 1 to 0 full health-dead scale required
for QALYs through the inclusion of an additional attribute, often
called DCETTO.
33-35 This technique has been successfully used on-
line in a number of valuation studies (for example21,36-38).
Selecting profiles for the DCE survey
The aim of the DCE was to generate utility values for the health
state classification system using duration by providing partici-
pants with pairwise choices of the HSC (8 dimensions) and
duration. The levels of the duration attribute were selected as 1, 4,
7, and 10 years in line with previous studies.21,36-38 The 8 di-
mensions combined with duration would result in .260 000
health profiles (49 = 262 144), meaning all possible combinations
of profiles could not be included in the DCE. A subset therefore
needed to be selected to enable estimation of utility values for the
HSC.
Although the DCE task is easy to understand, each pairwise
choice would have 18 pieces of information (9 per health profile),
which would increase the cognitive burden for participants
making choices. We simplified the cognitive task by constraining
the number of dimensions from the DMD-QoL that could vary in
each pairwise choice to 4.39,40 This means that for each pairwise
choice, participants only saw differences in severity in 4 of the 8
out of the DMQ-QoL HSC and duration; each of the other 4 di-
mensions were the same.
Ngene 1.2.141 was used with a candidate set (n = 22 336) of
random pairs that had the required constraints across 4 di-
mensions. The severity levels for each dimension were treated as
categorical and duration was treated as continuous. The model
included interaction terms between the levels for each dimension
and duration to allow estimation of the associated disutility. To
optimize and select the design, we maximize C-efficiency, which
focuses on the ratio of coefficients, which will be used to estimate
a value set. We used a willingness to pay approach derived using
the modified Fedorov algorithm with small nonzero priors for the
interaction terms to denote monotonically increasing severity in
levels within each dimension.41,42
The number of choice tasks for DCEs with 2 alternatives needs
to be at least as large as the number of parameters to be esti-
mated.43 A recent review suggested that the number of choice
tasks in experiments ranged from 12 to 3160 but were typically
around 150 to 200.29 Therefore, we selected 180 choice sets to
achieve both good coverage of the design space and a large
enough number of observations per choice pair to allow estima-
tion of probabilities for each.
Respondents were purely randomly allocated 9 of the 180
choice sets in the survey. To examine respondent engagement and
understanding, all respondents also answered the same practice
DCE task and the same dominance DCE task. Both the practice and
dominance DCE tasks had one dominant health profile (ie, a
health profile that had a better or same level across all attributes
than the profile to which it was being compared). The 9 DCE
choice sets that were randomly selected from the design and the
dominance DCE task were randomly ordered for each respondent.
DCE survey
Respondents were recruited using an existing online panel
from a market research agency, and quotas were set for age and
sex to ensure a representative sample of the UK population in
terms of age and sex according to the 2011 UK census. Members of
the online panel received an invite to the survey in their agency
portal and the survey remained open until all combined age and
sex quotas for a sample size of 1000 were met. Survey respondents
were thanked for their participation with a nominal number of
vouchers that can be accumulated and exchanged for goods.
The survey began with an information sheet about the survey
and informed consent was taken prior to starting the survey. The
survey had 3 stages. First, respondents completed sociodemo-
graphic, health, and QoL questions. Respondents also completed
the classification system to familiarize respondents with the de-
scriptions of the health state profiles used in the survey. Partici-
pants were not informed that the classification system (or later
health states) was for people with DMD, and DMD was not
mentioned throughout the survey. Second, respondents
completed one practice DCE question that explained the question
and gave feedback about their choice, enabling respondents to
amend their choice and complete the practice question again.
Respondents then completed 10 DCE tasks, 9 were selected from
the design and 1 was a dominance task (see Fig. 1 for an example
of the DCE task). Third, respondents completed 2 questions about
how difficult the DCE tasks were to understand and answer.
Yellow highlighting was used to indicate where the 2 profiles
differed to make the task easier to understand for respondents,
and this technique has been successfully used previously.21,39 Prior
to undertaking the main survey, the survey was soft launched
with 100 participants and the data analyzed. Because no changes
were made to the survey following the soft launch, this data is
included in the final dataset. The research received ethical
approval from the UK National Health Service (NHS; REC refer-
ence: 18/SW/0055).
Analysis
The sociodemographic and health characteristics of the sample





where mij represents the utility of individual i for health profile
j,aiis an individual specific constant term, εij represents the error
term, b1 is the coefficient for duration in life years t and b
0
2 rep-
resents the coefficients on the 24 interaction terms of duration
and severity levels of the dimensions comprised of levels 2, 3 and
4 (level 1 is the baseline). Using this specification, duration was
modeled as a linear and continuous variable. This assumption was
examined by modelling duration as a categorical variable and
plotting the duration coefficients.44
Model estimation was undertaken in Stata version 15 using the
conditional logit fixed effects model with cluster adjusted stan-
dard errors. Model performance was examined using the sign,
significance and logical consistency of coefficients, log likelihood
and pseudo R-squared.
The coefficients generated using this model specification are
latent values that are not anchored onto the 1 to 0 full health-dead
scale required to generate QALYs. The coefficients are anchored
onto the 1 to 0 full health-dead scale using a widely used tech-
nique,30 which uses the marginal rate of substitution, calculated
by dividing the coefficient for each level g of each attribute d by
the coefficient for duration,
b2gd
b1
, and standard errors were calcu-
lated using the Delta method.
For the anchored results to be used to generate health state
utility values, utility values must decrease or remain the same as
health worsens. To ensure this a consistent model was estimated,
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where adjacent inconsistent coefficients were merged into a sin-
gle variable. The use of the consistent model ensures a value set
where a worsening in health leads to the same or lower utility
values and is a widely used approach (for example19,20,37,45,46).
Robustness of the results was examined by estimating the
models excluding respondents who may not have understood or
engaged with the survey: respondents who did not choose the
dominant profile in the practice question; respondents who did
not choose the dominant profile in the dominance question;
respondents who found the survey difficult to understand; and
respondents who found the survey difficult to answer.
Preference heterogeneity, where preferences vary across
respondents, was examined using interaction effects for sex, age,
health, and employment status, and their sign, significance, and
impact on anchored coefficients was considered.
Results
Classification system
Eight items from the DMD-QoL were selected for the HSC (with
duration forming the maximum, ninth attribute). The data used to
help aid item selection is included in Table 1. Selection was con-
ducted for each factor (physical function, social participation,
psychological impact) separately.
For physical functioning, out of 3 possible items, the items
“I found it hard to use my hands” (difficulty using hands) and
“I found it hard to breathe” (difficulty breathing) were selected for
the HSC and “I found it hard to eat” (difficulty eating) was drop-
ped. The former 2 items produced the largest spread across the
latent factor and difficulty eating correlated the most highly with
the other items (particularly use of hands, r = .75). Although all
items in the physical functioning subscale displayed disordered
thresholds, they did not if analyzed in combination with the other
DMD-QoL items as an overall scale.14 Furthermore, it was
considered more important to retain representation of this factor
in the HSC than to omit all physical functioning items based on
this criterion.
For social participation, out of 3 possible items, the items
“I found it hard to get around” (mobility) and “I could take part in
the things I wanted to” (participation) were taken forward for the
HSC and item “I could take part in things with my friends”
(friends) was dropped. Friends had inadequate item fit, the high-
est average intra-factor correlation, and also had the highest
proportion of missing data (5.88%). Mobility was considered a
critical item in DMD-QoL development work.14 Although mobility
and friends had the largest spread across the latent continuum,
the difference was marginal. Furthermore, participation was
considered a broader term than friends and potentially inclusive
of it, so was preferred for inclusion in the HSC (participation and
friends correlated at r = 0.59).
Finally, for psychological impact, 4 of 8 possible items were
selected for the HSC: “I was in pain” (pain), “I felt tired” (tired-
ness), “I felt good about myself” (feeling good about yourself),
“I felt worried” (worry). The items “I felt unhappy” (unhappiness)
and “I found it hard to talk to people” (communication) were
eliminated as they had inadequate item fit and the latter was
noted as potentially ambiguous in earlier development work.14
The items “I felt embarrassed” (embarrassment) and “I felt
angry” (anger) were eliminated as it was perceived to be too
situational, with potential implausibility in feeling embarrassed or
angry “all of the time” (reflected in the lowest percentage of re-
sponses at the floor for these items). Both worry and feeling good
Figure 1. Survey screenshot of a discrete choice experiment task.
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about yourself were considered important to include given their
prominence in earlier qualitative work.14 Tiredness and pain were
selected to enhance spread across the latent factor and both items
showed good independence, motivating their inclusion in the HSC.
Although tired was the only item to show potential DIF by age,
with younger people reporting more tiredness, there are potential
explanations for this result, including that children are more
mobile and may experience greater fatigue as a consequence.14
Accordingly, it was considered important to retain the item in
the HSC due to its spread in the IRT analysis. The classification
system is detailed in Fig. 2.
The sample
The socioeconomic and health characteristics of the sample are
presented and compared with the UK general population in
Table 2. The sample has 1043 respondents and is representative of
the UK population in terms of age and sex. Approximately half of
the sample has a university degree or equivalent qualification.
Compared to the UK population, the sample has smaller pro-
portions of respondents who are employed, retired or students,
and has a proportion of respondents who are furloughed (because
the survey was undertaken during the coronavirus 2019 [COVID-
19] pandemic). The majority of respondents are either in very
good or good health, with mean EQ-5D-5L utility of 0.792 (scored
using47). DMD-QoL responses demonstrate the health problems
present in the sample, where many respondents reported pain,
tiredness, worry, and problems with both participation and feeling
good about themselves. The majority of participants completed
the survey on a laptop or desktop (93.5%) with the remainder
completing the survey using a tablet (6.5%).
Understanding and engagement
The proportion of respondents reporting that the DCE tasks
were difficult to understand was relatively small (12.7%), whereas
the proportion of respondents reporting that they found the DCE
tasks hard to answer was large (39.6%). This indicates that while
most respondents understood the tasks, a proportion of re-
spondents found it difficult to choose which health profile they
thought was best. The majority of respondents correctly chose the
dominant health profile in the practice DCE task (90.1%) and
dominance DCE task embedded in the survey (86.6%).
Regression analysis
The regression analyses are reported in Table 3. Results are
reported for the standard model that estimates coefficients for all
interactions between the severity levels 2, 3, and 4 for every
dimension with duration, and also for a fully consistent model
where adjacent inconsistent coefficients are merged into a single
variable.
Table 1. Summary of psychometric and IRT data used to help item selection.


























I found it hard to
use my hands
6.86 41.18 0.00 0.68 1.79 0.59-3.73 0.59 0.59 Yes
I found it hard to
eat
6.86 57.84 2.94 0.69 1.02 20.17 to 2.96 0.77 0.66 Yes
I found it hard to
breathe
1.96 81.37 0.98 0.62 -0.60 21.80 to 1.34 1.21 0.96 Yes
Psychological
impact
I was in pain 1.96 37.25 0.00 0.32 1.64 20.69 to 4.34 1.19 1.30
I felt tired 5.88 3.92 0.00 0.28 3.42 1.09 to 6.12 0.86 0.85 Age
I found it hard to
talk to people
5.88 43.14 0.00 0.34 1.70 20.63 to 4.40 1.54 1.39
I felt good about
myself
15.69 4.90 2.94 0.38 3.12 0.79 to 5.82 0.93 0.96
I felt unhappy 1.96 18.63 0.00 0.44 2.12 20.22 to 4.82 0.49 0.47
I felt embarrassed 0.98 36.27 2.94 0.37 1.60 20.73 to 4.30 0.88 0.89
I felt worried 5.88 14.71 0.98 0.44 2.78 0.45 to 5.48 0.64 0.61
I felt angry 0.98 24.51 0.00 0.43 2.27 20.06 to 4.97 0.69 0.68
Social participation
I found it hard to
get around
19.61 19.61 0.00 0.51 1.96 20.41 to 3.97 0.91 0.94
I could take part in
the things I
wanted to
16.67 5.88 1.96 0.51 2.26 20.12 to 4.27 0.72 0.73
I could take part in
things with my
friends
10.78 8.82 5.88 0.60 2.90 0.53-4.91 0.42 0.43
Note. N = 102.
DIF indicates differential item functioning; IRT, item response theory; MSQ, mean squared residual.
*Based on average correlation with other items in the same factor.
†DIF tested by report method (self-report vs proxy) and age ($16 y vs ,16 y). DIF not assessed for the physical and social subscales due to having ,4 items.
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For the latent estimates (unanchored models) in the standard
model, the coefficients for all levels of all dimensions multiplied
by duration are negative as expected, with the exception of
participation level 2 and feel good about yourself levels 2 and 3.
All other coefficients are logically consistent, whereas severity
worsens, the utility decrement increases. The duration coefficient
(LY) has the expected positive coefficient, demonstrating that in-
dividuals prefer to live longer meaning that higher levels of
duration have higher utility. The consistent model merges
participation levels 1 and 2 as well as feeling good about yourself
levels 1 and 2. This means that for these dimensions there is no
difference in utility between the levels all of the time and a lot of
the time. The consistent model is logically consistent across all
dimensions and 18 of 25 coefficients are significant. The incon-
sistent coefficients are for the milder levels of the dimensions and
in particular for the tired dimension.
The anchored model is reported for the consistent model,
where the utility decrements are anchored onto the 1 to 0 full
health-dead scale. These are also plotted on Fig. 3. Across all the
dimensions, pain and feeling good about yourself have the largest
utility decrements for level 4, whereas the tired dimension has
very small utility decrements for all severity levels (that are
noticeably smaller than all other dimensions), meaning that these
are the most and least important dimensions respectively in terms
of their impact on utility.
Utility values for each health state are generated by adding the
sum of the utility decrements to 1. For example, health state
33211111 has a utility value of 0.702 (calculated as
11(20.20920.08420.005)). The best state defined by the classi-
fication system has a value of 1 and the worst state defined by the
classification system has a value of 20.559 (worse than dead).
Robustness analyses are reported in Appendix Table 1 in
Supplemental Materials found at https://doi.org/10.1016/j.jval.2
021.03.007, where the standard regression model is estimated
excluding respondents are who may not have understood or
engaged with the DCE tasks. These models have the same logical
inconsistencies and the same insignificant coefficients as the
standard model estimated using the full sample, suggesting that
the models are robust to potential issues of participant engage-
ment or comprehension.
Figure 2. DMD-QoL-8D classification system for valuation. Participation and feeling good about yourself are both reverse ordered. The
ordering of some of the items has been changed in comparison to the order in which the items appear in the DMD-QoL. Labels in


































You never find it hard to get around
You never find it hard to use your hands
You find it hard to get around sometimes
You find it hard to get around a lot of the time
You find it hard to use your hands a lot of the time
You find it hard to use your hands all of the time
You never find it hard to breathe
You find it hard to breathe sometimes
You find it hard to breathe a lot of the time
You find it hard to breathe all of the time
You are never in pain
You are in pain sometimes
You are in pain a lot of the time
You are in pain all of the time
You never feel tired
You feel tired sometimes 
You feel tired a lot of the time 
You feel tired all of the time
You never feel worried
You feel worried sometimes
You feel worried a lot of the time
You feel worried all of the time
You feel take part in the things you want to all of the
time
You can take part in the things you want to a lot of the
time
You can take part in the things you want to sometimes
You can never take part in the things you want to
You feel good about yourself all of the time
You feel good about yourself a lot of the time
You feel good about yourself sometimes
You never feel good about yourself
You find it hard to get around all of the time












6 VALUE IN HEALTH - 2021
Table 2. Sample of DCE survey respondents.
Sociodemographic characteristics Rasch measurement
transactions






Mean age (SD) 47.9 (17.6)




PhD or equivalent doctoral level qualification 3.8
Masters or equivalent higher degree level qualification 14.8
Bachelors or equivalent first degree level qualification 33.0
A-level or equivalent post-secondary level qualification 24.2
GCSE or equivalent secondary level qualification. 19.9









Long term sick 4.3 3.6
None of the above/prefer not to say 2.2 0.9
Health Sample (n = 1043), %





Prefer not to say 0.2
EQ-5D-5L Mean (SD) 0.792 (0.236)
Understanding and engagement
Difficulty to answer DCE tasks Very difficult to answer 5.5
Quite difficult to answer 34.1
Neither difficult nor easy to answer 19.0
Fairly easy to answer 28.1
Very easy to answer 13.3
Difficulty to understand DCE tasks Very difficult to understand 2.7
Quite difficult to understand 10.0
Neither difficult nor easy to understand 17.6
Fairly easy to understand 35.1
Very easy to understand 34.6
Time in minutes taken to complete survey Mean (SD) 9.61 (6.31)
Interquartile range 5.55 to 11.95
Median 8.14
Practice question Selected dominant option 90.1%
Dominance question Selected dominant option 86.6%
DCE indicates discrete choice experiment; GCSE, General Certificate of Secondary Education.
*Age distribution is here reported as the percentage of all adults aged $18 years old.
†Statistics for England in the Census 2011. The census includes persons $16 years old, whereas this study only surveys persons aged $18 years old.
‡The survey was conducted July to August 2020 when in the United Kingdom a furlough scheme was in operation where due to the coronavirus 2019 pandemic some
employees were placed on temporary leave and the UK government paid 80% of their wages.
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Table 3. Regression analysis of DCE survey responses.
Standard model Consistent model Anchored coefficients of consistent model
Mobility2_LY 20.025* 20.026* Mobility2 20.064*
(0.008) (0.007) (0.023)
Mobility3_LY 20.084* 20.084* Mobility3 20.209*
(0.000) (0.000) (0.021)
Mobility4_LY 20.089* 20.085* Mobility4 20.213*
(0.000) (0.000) (0.023)
Hands2_LY 20.021† 20.020† Hands2 20.051†
(0.018) (0.023) (0.022)
Hands3_LY 20.033* 20.034* Hands3 20.084*
(0.000) (0.000) (0.022)
Hands4_LY 20.076* 20.077* Hands4 20.191*
(0.000) (0.000) (0.022)
Breathe2_LY 20.004 20.002 Breathe2 20.005
(0.612) (0.831) (0.022)
Breathe3_LY 20.040* 20.038* Breathe3 20.095*
(0.000) (0.000) (0.022)
Breathe4_LY 20.078* 20.075* Breathe4 20.186*
(0.000) (0.000) (0.022)
Pain2_LY 20.044* 20.046* Pain2 20.114*
(0.000) (0.000) (0.023)
Pain3_LY 20.099* 20.096* Pain3 20.240*
(0.000) (0.000) (0.021)
Pain4_LY 20.115* 20.116* Pain4 20.288*
(0.000) (0.000) (0.025)
Tired2_LY 20.001 20.001 Tired2 20.003
(0.938) (0.927) (0.029)
Tired3_LY 20.018‡ 20.014 Tired3 20.035
(0.091) (0.170) (0.025)
Tired4_LY 20.022† 20.018† Tired4 20.045†
(0.016) (0.047) (0.022)
Worried2_LY 20.007 20.006 Worried2 20.015
(0.430) (0.479) (0.020)
Worried3_LY 20.024† 20.023† Worried3 20.057†
(0.011) (0.015) (0.023)




Take_Part3_LY 20.011 20.020† Take_Part3 20.051†
(0.331) (0.040) (0.024)




Feel_Good3_LY 0.000 20.014 Feel_Good3 20.034
(0.980) (0.110) (0.021)
continued on next page
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Models examining preference heterogeneity across socio-
demographic and health characteristics are reported in the
Appendix Tables 2 and 3 in Supplemental Materials found at
https://doi.org/10.1016/j.jval.2021.03.007. In general, males,
younger participants aged 18 to 24 years and employed partici-
pants have smaller anchored utility decrements, while older par-
ticipants aged $65 years old and participants in fair or poor
general health have larger utility decrements, though many co-
efficients were insignificant.
Comparing DMD-QoL-8D and EQ-5D-5L
The consistent model was used to generate DMD-QoL-8D util-
ities on the data used to derive the classification system.14 For the
57 participants with both DMD-QoL-8D and EQ-5D-5L data,
DMD-QoL-8D had mean (SD) 0.675(0.256) with interquartile range
(IQR) 0.304, and EQ-5D-5L had mean (SD) 0.206(0.346) and IQR
0.643. The measures are strongly correlated at 0.65.
Discussion
This report has presented DMD-QoL-8D, a DMD-specific PBM.
The research has derived the health state classification system
from the DMD-QoL, valued health states from the DMD-QoL using
DCE with a duration attribute, DCETTO, and modeled these results
to generate utility values for all health states defined by the
classification system. The generation of this PBM has the advan-
tage that it is based upon a measure that has been developed with
input from patients, caregivers and clinicians and is patient-
focused and relevant for people with DMD. The measure can be
used to estimate utility values to calculate QALYs for assessing the
cost-effectiveness of new and existing interventions in DMD. The
classification systemwas valued by a representative sample of the
UK general population, as recommended to inform decision
making for agencies such as NICE.17
The consistent model is recommended to generate utility
values for the DMD-QoL-8D. The model has a large number of
significant and consistent coefficients, noting that there are 2
merged variables for participation levels 1 and 2 and feeling good
about yourself levels 1 and 2. The model includes all responses,
and does not exclude any participants on the basis of engagement
and understanding or impose any potentially subjective judge-
ments around whose preferences are appropriate or inappro-
priate, and benefits from a large sample size of .1000
participants. The utility values have a large range from
1 to 20.559, where the worst state is considerably lower than
dead at zero. This range in utility values is similar to UK values for
EQ-5D-3L (1 to 20.594).48
Overall, the sample had good understanding, with the majority
of respondents reporting that the DCE tasks were easy to under-
stand (69.7%), and the majority of respondents correctly choosing
the dominant option in the practice question (90.1%) and purpo-
sively designed dominance question (86.6%). This is higher than
the mean of 82% found in a recent article that assessed dominance
questions across 22 studies whilst developing and testing a tool to
assess internal validity of DCE data.49 Many respondents did state
that the DCE tasks were difficult to choose an answer (39.6%),
which may be expected since this requires the imagination of
hypothetical health states, trading between quality and quantity of
life and the simultaneous consideration of many pieces of
information.
Two of the dimensions that capture QoL (participation and
feeling good about yourself) rather than health have amongst the
largest utility decrements for the level 4, but for level 2 this was
merged with level 1 meaning that there is no distinction in utility
between all of the time and a lot of the time for these dimensions.
There is a possibility that this may have been affected by the
Table 3. Continued
Standard model Consistent model Anchored coefficients of consistent model




Observations 18 770 18 770
Log likelihood 25249 -5255
Rho-squared 0.193 0.192
Significant coefficients 20/25 18/23
Note. For the standard model and consistent model P values are in parentheses. For the anchored coefficients standard errors are in parentheses.
Breathe indicates difficulty breathing; DCE, discrete choice experiment; hands, difficulty using hands; feel good, feeling good about yourself; LY, life years or duration;




Figure 3. Plot of anchored coefficients to generate value set.
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reverse ordering of these 2 dimensions because all of the time is
the best level for these 2 dimensions but the worst level for all of
the other dimensions. However, the coefficients for levels 3 and 4
are logically consistent as expected, and significant with the
exception of feeling good about yourself level 3. Tired has smaller
coefficients across all severity levels in comparison to all other
dimensions. Tiredness or vitality has also been found to have small
utility decrements in other PBM, including recently valued mea-
sures in the UK of generic SF-6Dv238 and EORTC-QLU-C10D for
cancer.36
The factor analysis of the DMD-QoL identified 3 factors rather
than the 7 themes (physical aspects, social relationships, auton-
omy, identity, daily activities, feelings and emotions, healthcare
and support) identified in the qualitative analysis undertakenwith
people with DMD that was used to generate DMD-QoL items. The
selected items from the DMD-QoL that form the DMD-QoL-8D
classification system cover 5 of the 7 themes, and the 2 themes
of daily activities and social relationships are not directly repre-
sented, but items are included, which otherwise relate to them.
Daily activities was captured in the DMD-QoL by a single item
around difficulty eating, and this correlated highly with difficulty
using hands and difficulty breathing, which were both included in
the classification system. Social relationships were captured using
items of difficulty talking to people and being able to take part in
things with friends. The former was noted as potentially ambig-
uous in earlier development work14 and the latter was not inde-
pendent to other items in its factor (that were included in the
classification system), had the highest proportion of missing data
and correlated highly with other items that were included in the
classification system. Therefore, given the need for item reduction
in developing the PBM, these items were not considered as
favorable for inclusion. Although this means that the classification
system does not include items purposively worded to capture
these 2 themes as coded in the qualitative work, the classification
system does include items that are correlated with the absent
themes according to the psychometric analyses conducted here.
The data used for the psychometric analyses that informed the
derivation of the classification system has a relatively small sam-
ple (n = 102) and is the only currently available DMD-QoL dataset.
Although this is not unexpected, because there are significant
challenges in the collection of QoL data in rare conditions, it does
mean that the classification system has not been validated in an
independent dataset. Therefore, when new DMD-QoL data be-
comes available it is recommended that the classification system
and factor structure of the DMD-QoL are validated. This data were
also used to compare EQ-5D-5L and DMD-QoL-8D utilities, where
EQ-5D-5L has lower mean and larger IQR. However, this is based
on a small sample (n = 57). Comparison of the psychometric
performance of DMD-QoL-8D and EQ-5D-5L using an independent
dataset with larger sample size, preferably associated with an
intervention to be able to compare responsiveness, is recom-
mended. However, the findings here suggest that DMD-QoL-8D
and EQ-5D-5L produce different utility values and hence the
mixing of utility values from both measures in an economic model
would need to be carefully managed, because both the utility and
change in utility is expected to vary widely across the measures.
Where comparability across conditions and interventions is
required, one option is to use a generic preference-based measure
in base case economic analyses to enable that comparability, and
DMD-QoL-8D in sensitivity analyses because it has greater content
validity and includes aspects deemed important to patients.
DMD affects boys and adults, and hence the DMD-QoL has
been designed for use for all people with DMD regardless of their
age. There is a growing literature around the valuation of PBM for
children and adolescents, with no consensus as to how they
should be valued,50 but this raises questions about whose values
(eg, adults or adolescents) and from which perspective (for
themselves or imagining, say, a 10-year-old child). This measure
was valued using a representative sample of adults from their own
perspective, because this has the advantage that it is both what is
done for adult preference-based measures and what is recom-
mended for adult measures by agencies such as NICE.17 Adults
valuing from their own perspective also has been used to value
generic HUI3, a measure that can be used both for children and
adults,51 although note a different approach was used for HUI2
(which is also a measure that can be used for children and
adults).52 However, one option is that the measure could have
been valued from a sample including both older adolescents and
adults, since these are the population (as well as children) that
have DMD.
The DCE survey was conducted during the COVID-19
pandemic, and it is possible that this may have impacted on
preferences. In particular, some of the attributes were impacted by
COVID-19, including difficulty breathing, and also on the wider
population as a result of lockdown, including participation and
potentially worry. The impact of the pandemic on health prefer-
ences is currently unknown, although due to the nature of the
global pandemic it is likely that the impact on preferences will be
experienced for some time. One possibility is to examine whether
equivalent preferences are found in a future survey where the
same questions are answered, potentially on a smaller sample. It is
not expected that the mode of administration will have impacted
on preferences, because online surveys have been commonly used
in recent years and it is expected that they will become increas-
ingly popular in the years during and after the COVID-19
pandemic. There is an additional possibility that participants un-
dertaking the survey differed across their unmeasurable charac-
teristics to those who typically complete online surveys or
complete interviews in their own home. During the pandemic
everyone was encouraged to stay at home, and this may have
positively impacted on people’s availability and willingness to
complete online surveys particularly in the area of health.
Models exploring preference heterogeneity indicated signifi-
cant differences for age, sex, employment status, and general
health characteristics. However, the selected model does not
include interaction effects to reflect these since the model is
intended to reflect the preferences of the general population using
a single value set. Participants were purposively sampled to be
representative for age and sex and the sample is representative for
the proportion of employed individuals.
Potential limitations of the study include those arising through
the use of an online sample recruited via an existing online panel
managed by a market research agency. Although the use of these
samples is becomingly increasing common in health preference
research, concerns have been raised around the true representa-
tiveness of the sample that will not include the computer illiterate
or those with no internet access. Our sample has a high proportion
(51.6%) of people with a degree, suggesting the sample is not fully
representative regarding education. However, importantly the
online administration would include people that are shielding due
to COVID-19, which would have been missed using other modes of
administration. Second, lack of attendance to all dimensions and
duration in the DCE task is a criticism of the DCETTO technique and
may be further emphasized when the dimensions that vary across
the 2 profiles are highlighted in yellow thus encouraging re-
spondents to focus on the levels that change rather than all di-
mensions included in the profiles. However, the use of
highlighting is a recognized technique when there are a large
number of attributes in the DCE task. One final limitation is that
the approach adopted here differs to the elicitation technique used
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for EQ-5D-3L or EQ-5D-5L, which is the recommended measure
for agencies such as NICE.17 However, the same technique of
DCETTO has recently been used to value other measures in the UK
including generic SF-6Dv238 and EORTC-QLU-C10D in cancer,36
and it is emerging as a widely used technique to value PBM
more generally.31,32
This study has generated preference weights for the DMD-
QoL-8D, a DMD-specific PBM that has been derived to
generate utility values for people with DMD. These results can
be used to inform cost-effectiveness analyses of interventions in
DMD.
Supplemental Material
Supplementary data associated with this article can be found in the
online version at https://doi.org/10.1016/j.jval.2021.03.007.
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